Skip to main content
SXTP
NASDAQ Life Sciences

60 Degrees Pharmaceuticals Regains Nasdaq Compliance, Averting Delisting

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$3.75
Mkt Cap
$4.178M
52W Low
$1.36
52W High
$17.68
52W Position info
176% above low
Off High info
79% below high
Rel. Volume
Market data snapshot near publication time

SXTP has more than doubled off its 52-week low of $1.36.

Summary

60 Degrees Pharmaceuticals announced it has regained compliance with Nasdaq's minimum bid price rule, leading to the cancellation of its delisting hearing and ensuring its continued listing on The Nasdaq Capital Market.


Key Events · Corporate Governance and Compliance · SXTP

  • Regains Nasdaq Compliance

    The company was notified on February 11, 2026, that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share.

  • Delisting Hearing Cancelled

    As a result of regaining compliance, the delisting hearing before the Nasdaq Hearings Panel, previously scheduled for February 19, 2026, has been cancelled, and the matter is now closed.

  • Continued Nasdaq Listing

    The company's common stock and warrants will continue to be listed and traded on The Nasdaq Capital Market, reversing the prior delisting determination from January 23, 2026.


Analysis · SXTP · Life Sciences

This filing is highly significant as it announces that 60 Degrees Pharmaceuticals has successfully regained compliance with Nasdaq's minimum bid price requirement, thereby avoiding delisting. This positive development directly reverses the critical delisting notice received on January 23, 2026, which had posed an immediate threat to the company's stock exchange listing. The cancellation of the scheduled delisting hearing removes a major overhang and provides stability for the company, especially following its recent 1-for-4 reverse stock split on January 21, 2026, which was likely implemented to help achieve this compliance. Maintaining a Nasdaq listing is crucial for investor confidence and access to capital markets for a company of this size.

At the time of this filing, SXTP was trading at $3.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.2M. The 52-week trading range was $1.36 to $17.68. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SXTP - Latest Insights

SXTP
Jul 20, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.51
Real-time Price: $1.47 info
Change: -$0.040 (-3%) info
Market Cap: $3.962M info
SXTP
Jul 09, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.47 info
Change: -$0.110 (-7%) info
Market Cap: $3.962M info
SXTP
Jul 08, 2026, 8:01 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.50
Real-time Price: $1.47 info
Change: -$0.0339 (-2%) info
Market Cap: $3.962M info
SXTP
Jul 02, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $1.71
Real-time Price: $1.47 info
Change: -$0.240 (-14%) info
Market Cap: $3.962M info
SXTP
Jul 01, 2026, 8:02 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.69
Real-time Price: $1.47 info
Change: -$0.220 (-13%) info
Market Cap: $3.962M info